The following table shows the list of Horizon 2020 projects developed by "EXPRES2ION BIOTECHNOLOGIES APS". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | MultiViVax | H2020-EU.3.1.2. | participant | 25˙000.00 | 2017-01-01 | 722 |
2 | OptiMalVax | H2020-EU.3.1.2. | participant | 25˙000.00 | 2017-01-01 | 1203 |
3 | INDIGO | H2020-EU.3.1.2. | participant | 610˙337.00 | 2020-04-01 | 662 |
totale | 660˙337.00 |
This organization collaborated with partners in 10 countries.
Within the project MultiViVax this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | OVX | OSIVAX SAS (PRC) |
participant | FR | IMX | IMAXIO SA (PRC) |
participant | SE | NOVA | NOVAVAX AB (PRC) |
participant | FR | IRD | INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (REC) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | GRL | GENOME RESEARCH LIMITED (REC) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project OptiMalVax this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | UKRI | UNITED KINGDOM RESEARCH AND INNOVATION (REC) |
participant | FR | SUxUPMC | SORBONNE UNIVERSITE (HES) |
participant | FR | OVX | OSIVAX SAS (PRC) |
participant | NL | Janssen | JANSSEN VACCINES & PREVENTION BV (PRC) |
participant | FR | IMX | IMAXIO SA (PRC) |
participant | SE | NOVA | NOVAVAX AB (PRC) |
participant | AU | JCU | JAMES COOK UNIVERSITY (HES) |
participant | US | PATH | PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH (REC) |
participant | FR | IRD | INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (REC) |
participant | CH | UNIL | UNIVERSITE DE LAUSANNE (HES) |
participant | DK | SSI | STATENS SERUM INSTITUT (REC) |
participant | UK | GRL | GENOME RESEARCH LIMITED (REC) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | FR | UPMC | UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6 (HES) |
participant | UK | MRC | MEDICAL RESEARCH COUNCIL (REC) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | NL | RU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project INDIGO this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | EPVX | EPIVAX INC (PRC) |
participant | IN | CDSA | CLINICAL DEVELOPMENT SERVICES AGENCY (REC) |
participant | IN | THSTI | TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (REC) |
participant | FR | STA | STANIPHARM (PRC) |
participant | NL | LVX | LITEVAX BV (PRC) |
participant | NL | VCB | VIROCLINICS BIOSCIENCES BV (PRC) |
participant | FR | CVX | CELLVAX (PRC) |
participant | BE | UZ Gent | Universitair Ziekenhuis Gent (REC) |
participant | IN | SJRI | CBCI Society for Medical Education (HES) |
participant | IN | GENN | GENNOVA BIOPHARMACEUTICALS LIMITED (PRC) |
coordinator | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | IN | CSIR-IMTECH | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (REC) |
participant | IN | CMCV | CHRISTIAN MEDICAL COLLEGE VELLORE (HES) |
participant | BE | UGENT | UNIVERSITEIT GENT (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |